NYSE:DTC - Post Discussion
Solo Brands Inc
> Defence Investigates the Application of the Accum Hydrogel T
Post by
whytestocks on Aug 19, 2024 12:45pm
Defence Investigates the Application of the Accum Hydrogel T
NEWS: $DTC Defence Investigates the Application of the Accum Hydrogel Technology to Deliver GLP-1 in Order to Increase the Treatment Efficacy of Diabetes and Weight LossVancouver, British Columbia--(Newsfile Corp. - August 19, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce a pr...
DTC - Defence Investigates the Application of the Accum Hydrogel Technology to Deliver GLP-1 in Order to Increase the Treatment Efficacy of Diabetes and Weight Loss
Be the first to comment on this post